CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (Nasdaq:AKBA) today announced that it intends to offer to sell $60 million of shares of its common stock in an underwritten public offering. As part of this offering, Akebia Therapeutics, Inc. intends to grant the underwriters a 30-day option to purchase up to an additional $9 million of shares of its common stock.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
